FDA-approved GLP-1/GIP medications have established safety profiles when prescribed and monitored by a licensed physician, and are appropriate for many adults
At the biostation, we administer semaglutide as part of a well-rounded weight loss regimen that includes weekly monitoring and a complete weight loss protocol that includes nutritional guides and expert recommendations
Clinical signs of Plaquenil toxicity include maculopathy, retinal pigment epithelium changes, advanced retinopathy with bull's eye maculopathy characterized by a ring of parafoveal RPE depigmentation, central vision loss, decreased color vision, central scotomas, photopsia and visual field deficits
Clinical trials have shown promising results for Tirzepatide, with patients losing an average of 11 to 13.1% of their body weight over six months in a phase 2 trial, and even more encouraging results in phase 3 trials
This publication echoes that without any qualification